Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV's pipeline of antimalarial drugs
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Antimalarial drug availability
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Antimalarial drug toolkits
Artesunate injection dosage & administration
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Intellectual property rights (IPR)
Clinical centre partners by country
Our impact
Milestones
Malaria stories from the field
Antimalarial drugs for children
Gender equity
Global health security
Antimicrobial resistance to antimalarials
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
5 species of
Plasmodium
parasites
Lifecycle of malaria parasite
Malaria facts & statistics
Malaria treatment
History of antimalarial drugs
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
The Global Health Priority Box
About the Global Health Priority Box
Supporting information
Request the Global Health Priority Box
Terms & conditions
Malaria
Libre
Malaria
Libre
open innovation platform
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News
News
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
308 found
Ray Chambers appointed WHO Ambassador for Global Strategy
31 Oct 2018
Professor James McCarthy elected Fellow of Australian Academy of Health and Medical Sciences
31 Oct 2018
Single-dose tafenoquine for radical cure of
P. vivax
malaria submitted for regulatory approval in Brazil
21 Sep 2018
MMV Project of the Year 2017 awarded to Sanofi
10 Jul 2018
Strides Shasun’s rectal artesunate product receives WHO prequalification
21 Jun 2018
MMV deeply saddened by the loss of Prof. Ogobara Doumbo
11 Jun 2018
Australia renews commitment to MMV and R&D for malaria
08 Jun 2018
MMV partner Kelly Chibale in Fortune Greatest Leaders list 2018
30 Apr 2018
MMV’s contributions to malaria commended at MIM conference
27 Apr 2018
Major study confirms tolerability and high efficacy of 4 gold-standard malaria medicines, when used for repeated treatment over a 2 year period
29 Mar 2018
MMV welcomes Philip Welkhoff, new Malaria Program Director, BMGF
14 Feb 2018
MMV and DNDi deliver joint statement at WHO Executive Board
27 Jan 2018
MMV end-of-year review 2017
02 Jan 2018
WHO issues information note on correct use of rectal artesunate for severe malaria
18 Dec 2017
Unitaid awards MMV new supply side grant
08 Dec 2017
PLOS Medicine publishes New Malaria Eradication Road Map
01 Dec 2017
Two new MMV-supported research sites inaugurated in Ethiopia
30 Nov 2017
Two MMV partners receive international award
30 Nov 2017
Global malaria response “off track” in 2016
29 Nov 2017
USAID renews support to MMV with new grant
09 Nov 2017
100 million vials of injectable artesunate distributed since 2010
06 Nov 2017
MMV backs training course for study coordinators
01 Nov 2017
MMV and Transaid partner to tackle severe malaria in Zambia
31 Oct 2017
MMV hosts international drug discovery meeting in Geneva
26 Oct 2017
Three vivax research teams awarded MMV Project of the Year 2016
10 Oct 2017
MMV discovery partners receive ASBMB awards
09 Oct 2017
Everything you always wanted to know about malaria and more
03 Aug 2017
Dr Tedros Adhanom Ghebreyesus elected as the new Director-General of WHO
24 May 2017
MMV and partners launch “call to action” to G20 health ministers
22 May 2017
MMV launches new Severe Malaria Observatory
18 May 2017
MMV and Aga Khan Foundation Canada come together to tackle malaria in Mali
01 May 2017
New publication highlights efficacy of MMV048 against resistant strains of malaria
27 Apr 2017
New antimalarial compound treats and protects in a single dose
29 Mar 2017
MMV 4th in top 10 rare infectious disease drug developers
28 Mar 2017
Awa Marie Coll-Seck receives Best Minister Award
27 Feb 2017
MMV shines a light on malaria in Times Square
22 Feb 2017
RBM appoints new CEO
27 Jan 2017
MMV delivers statement at 140th session of the WHO Executive Board
27 Jan 2017
MMV welcomes the launch of the End Malaria Council
25 Jan 2017
MMV brings new partner Janssen Pharmaceuticals on board
19 Jan 2017
MMV end-of-year review 2016
22 Dec 2016
Swiss Malaria Group invites you to enter photo and video competition
17 Dec 2016
Cipla’s artesunate suppository first to be quality-assured by Global Fund
16 Dec 2016
World Malaria Report 2016 reveals improved malaria control for vulnerable but substantial gaps remain
13 Dec 2016
MMV partner GSK ranked first in the Access to Medicine Index – again
17 Nov 2016
MMV partner Prof. David Fidock wins the 2016 Advance Global Australian of the Year Award in Life Sciences
21 Oct 2016
First open source malaria publication describes new way to do drug discovery
14 Sep 2016
PLOS Pathogens
publishes the Malaria Box findings
28 Jul 2016
MMV awards seven endemic-region scientists Challenge Grants to ‘exploit the Pathogen Box’
25 Jul 2016
Malaria community mourns the tragic loss of Dr Sylvia Meek
23 May 2016
Endemic-Region Challenge Grants of USD 50,000 each available to exploit the Pathogen Box
31 Mar 2016
MMV welcomes WHO approval of 3-year shelf-life for antimalarial ASMQ
08 Mar 2016
Mr Yong Taek Chang, Chairman of Shin Poong Pharmaceutical passes away
07 Mar 2016
MMV delivers statement at WHO Executive Board meeting
29 Jan 2016
MMV welcomes George Osborne and Bill Gates’ £3 billion pledge for malaria
27 Jan 2016
MMV launches the Pathogen Box
14 Dec 2015
WHO reports a ‘dramatic decline’ in malaria burden since 2000
09 Dec 2015
Delivery of Coartem®
Dispersible
reaches a landmark of 300 million treatments
09 Dec 2015
Ray Chambers entrusts Chairmanship of MMV to Per Wold-Olsen
04 Dec 2015
European regulators grant Pyramax® a revised label
20 Nov 2015
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »